282 results on '"Kaiser, Christopher"'
Search Results
2. Bibliography
3. Index of ContemporaryAuthors
4. Index of Biblical and Post-Biblical Texts
5. Title Page, Copyright Page
6. Contents
7. Deity Christology in a Jewish Context
8. 1. Kyriocentric Visions in Early Judaism: Experiential, Literary, or Performative?
9. Abbreviations
10. 3. Kyriocentric Prayers and Devotions as the Context for Visions among Early Disciples of Jesus
11. 2. Motifs Associated with Kyriocentric Visions in Apocalyptic and Early Rabbinic Literature
12. Part I: Kyriocentric Visions in the Context of Crisis and Performative Prayer
13. 9. Three Movements that Marginalized Visions of the Anthropic Form of the Lord
14. 6. Kyriocentric Prayers and Devotions in the New Testament
15. 8. Four Alternative Tradition Histories or Textures in Early Christology
16. 7. Superposing Jesus Traditions and Deity Christology
17. 5. Traces of Kyriocentric Visions in the New Testament
18. 4. Conditions under which a Kyriocentric Vision Might Be Identified with a Deceased Human Being
19. PART II: Kyriocentric Visions as the Impetus for Early Deity Christology
20. PART III: Modifications of the Lord-Jesus Identification in the New Testament and the Early Church
21. Conclusion: Accomplishments and Some Unresolved Issues
22. Media Literacy Practices to Prevent Obesity and Eating Disorders in Youth
23. The Shared Course Initiative
24. Conserved defense responses between maize and sorghum to Exserohilum turcicum
25. The Agencies of God’s Word and Spirit: Modern Science as a “Sacred Reminder”
26. Learn Quantum Computing with Python and Q#: A hands-on approach
27. Societal Foundation: The Paradox of Science-Fostering Social Systems
28. Four Foundations of Scientific Endeavour
29. Anthropological Foundation: The Paradox of Science-Fostering Intelligence
30. Foundations of Scientific Endeavour and the Unity of Knowledge
31. Cosmic Foundation: The Challenge of a Lawful Universe
32. Cultural Foundation: The Challenge of Science-Fostering Beliefs
33. Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents
34. Xenophobia or Immigration Policies? A Field Experiment on Hiring Discrimination of High-Skilled Immigrants
35. Supplemental Table 3 from Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma
36. Supplemental Table 2 from Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma
37. Supplemental Figure Legend from Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma
38. Supplemental Figure from Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma
39. Supplemental Table 1 from Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma
40. Redrawing the Boundaries: A Constructivist Approach to Combating Student Apathy in the Secondary History Classroom
41. Meta-Analysis Comparing Efficacy and Safety of First Generation Drug-Eluting Stents to Bare-Metal Stents in Patients With Diabetes Mellitus Undergoing Primary Percutaneous Coronary Intervention
42. Phase 2 study of tabalumab, a human anti‐B‐cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma
43. Genetic mapping of sorghum resistance to an Illinois isolate of Colletotrichum sublineola
44. Habitat Structure Affects Reproductive Success of the Rare Endemic Tree Syzygium mamillatum (Myrtaceae) in Restored and Unrestored Sites in Mauritius
45. Investigation of electron-induced cross-linking of self-assembled monolayers by scanning tunneling microscopy
46. A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer
47. A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma
48. A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma
49. Patent drafter estoppel: why didn't Sage Products create a new foreseeability limitation on the application of the doctrine of equivalents?
50. Take it or leave it: Monsanto v. McFarling, Bowers v. Baystate Technologies, and the Federal Circuit's formalistic approach to contracts of adhesion.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.